BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19251086)

  • 21. Concepts and developments in radiosensitization of mammalian cells.
    Stratford IJ
    Int J Radiat Oncol Biol Phys; 1992; 22(3):529-32. PubMed ID: 1735691
    [No Abstract]   [Full Text] [Related]  

  • 22. Perfluorochemical emulsions: oxygen breathing in radiation sensitization and chemotherapy modulation.
    Teicher BA; Herman TS; Frei E
    Important Adv Oncol; 1992; ():39-59. PubMed ID: 1582677
    [No Abstract]   [Full Text] [Related]  

  • 23. Biology-based combined-modality radiotherapy: workshop report.
    Mason KA; Komaki R; Cox JD; Milas L
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):1079-89. PubMed ID: 11429236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer Radiosensitizers.
    Wang H; Mu X; He H; Zhang XD
    Trends Pharmacol Sci; 2018 Jan; 39(1):24-48. PubMed ID: 29224916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxic cell radiosensitizers.
    Fowler JF
    Strahlentherapie Sonderb; 1978; 75():12-9. PubMed ID: 400196
    [No Abstract]   [Full Text] [Related]  

  • 26. Keynote address: hypoxic cell radiosensitizers: where next?
    Brown JM
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):987-93. PubMed ID: 2649468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Notch inhibitor: a promising carcinoma radiosensitizer.
    Yu SD; Liu FY; Wang QR
    Asian Pac J Cancer Prev; 2012; 13(11):5345-51. PubMed ID: 23317182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modification of radiotherapy by radiosensitizers and cancer chemotherapy agents. I. Radiosensitizers.
    Coleman CN
    Semin Oncol; 1989 Jun; 16(3):169-75. PubMed ID: 2658080
    [No Abstract]   [Full Text] [Related]  

  • 29. Natural Radiosensitizers in Radiotherapy: Cancer Treatment by Combining Ionizing Radiation with Resveratrol.
    Komorowska D; Radzik T; Kalenik S; Rodacka A
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiation interactions with taxanes, old and new.
    Mason KA
    Radiat Res; 2005 Jun; 163(6):705-6. PubMed ID: 16044506
    [No Abstract]   [Full Text] [Related]  

  • 31. Emerging targets for radioprotection and radiosensitization in radiotherapy.
    Kumar S; Singh RK; Meena R
    Tumour Biol; 2016 Sep; 37(9):11589-11609. PubMed ID: 27318945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel radiation sensitizers targeting tissue hypoxia.
    Rowinsky EK
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):61-70. PubMed ID: 10550828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of Soft Tissue Sarcoma Cell Radiosensitivity by Poly(ADP-ribose) Polymerase-1 Inhibitors.
    Mangoni M; Sottili M; Salvatore G; Meattini I; Desideri I; Greto D; Loi M; Becherini C; Garlatti P; Delli Paoli C; Dominici L; Gerini C; Scoccianti S; Bonomo P; Silvano A; Beltrami G; Campanacci D; Livi L
    Radiat Res; 2018 Nov; 190(5):464-472. PubMed ID: 30067444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploiting synergies between radiation and oncolytic viruses.
    Harrington KJ; Melcher A; Vassaux G; Pandha HS; Vile RG
    Curr Opin Mol Ther; 2008 Aug; 10(4):362-70. PubMed ID: 18683101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stereotactic ablative radiotherapy in the framework of classical radiobiology: response to Drs. Brown, Diehn, and Loo.
    Meyer J; Timmerman R
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1599-600; author reply 1600. PubMed ID: 21414517
    [No Abstract]   [Full Text] [Related]  

  • 36. Radiation modifiers: treatment overview and future investigations.
    Thomas CT; Ammar A; Farrell JJ; Elsaleh H
    Hematol Oncol Clin North Am; 2006 Feb; 20(1):119-39. PubMed ID: 16580560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sulfoglycolipids as candidate antiangiogenic radiosensitizers.
    Miura M; Sakimoto I; Ohta K; Sugawara F; Sakaguchi K
    Anticancer Drugs; 2007 Jan; 18(1):1-5. PubMed ID: 17159496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Theoretical bases for using modifying agents in the radiation therapy of malignant neoplasms (the Modifier program)].
    Kuzin AM; Tsyb AF; Iarmonenko SP; Pelevina II; Konopliannikov AG
    Radiobiologiia; 1981; 21(5):744-51. PubMed ID: 7031758
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of radiosensitizing drugs in the management of cancer.
    Adams GE
    Invest Cell Pathol; 1979; 2(4):303-8. PubMed ID: 396284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimetabolite radiosensitizers.
    Shewach DS; Lawrence TS
    J Clin Oncol; 2007 Sep; 25(26):4043-50. PubMed ID: 17827452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.